Contineum Therapeutics (CTNM) Assets Average (2024 - 2025)
Contineum Therapeutics (CTNM) has 2 years of Assets Average data on record, last reported at $186.9 million in Q3 2025.
- For Q3 2025, Assets Average fell 14.55% year-over-year to $186.9 million; the TTM value through Sep 2025 reached $186.9 million, down 14.55%, while the annual FY2024 figure was $171.6 million, N/A changed from the prior year.
- Assets Average reached $186.9 million in Q3 2025 per CTNM's latest filing, down from $190.6 million in the prior quarter.
- Across five years, Assets Average topped out at $218.7 million in Q3 2024 and bottomed at $127.0 million in Q1 2024.